MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
María Monteagudo(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Luis J. Leandro‐García(Spanish National Cancer Research Centre), María Currás-Freixes(Spanish National Cancer Research Centre), Hanna Remde(University of Würzburg), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Nuria Palacios García(Radboud University Nijmegen), Giovanna Roncador(Spanish National Cancer Research Centre), Eduardo Gil(Spanish National Centre for Cardiovascular Research), Ángel Fernández-Sanromán(The Francis Crick Institute), Felix Beuschlein(University of Zurich), Martin Faßnacht(University of Würzburg), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), María Calatayud Gutiérrez(Research Institute Hospital 12 de Octubre), Fátima Al‐Shahrour(Broad Institute), Adrià López‐Fernández(Vall d'Hebron Hospital Universitari), Judith Favier(Inserm), Sara Mellid(Spanish National Cancer Research Centre), Clara Reglero(Spanish National Cancer Research Centre), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Bruna Calsina(Spanish National Cancer Research Centre), Rita María Regojo(Hospital Universitario La Paz), Elena Piñeiro-Yáñez(Spanish National Cancer Research Centre), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Cristina Lamas(Hospital General Universitario de Albacete), María Isabel Del Olmo-García(Hospital Universitari i Politècnic La Fe), Letizia Canu(Azienda Ospedaliero-Universitaria Careggi), Sandra Rodríguez(Spanish National Cancer Research Centre), Óscar Sanz Guadarrama(Centre for Biomedical Network Research on Rare Diseases), Natalia Martínez‐Puente(Instituto de Salud Carlos III), Alberto Díaz‐Talavera(Centro de Biología Molecular Severo Ochoa), Nelly Burnichon(Inserm), Svenja Nölting(University of Zurich), Alexandre Buffet(Inserm), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Marcus Quinkler(Charité - Universitätsmedizin Berlin), Alberto Cascón(Spanish National Cancer Research Centre), Elena Rapizzi(El.En. Group (Italy)), Milton E. Salazar-Hidalgo(Spanish National Cancer Research Centre), Ester Arroba(Spanish National Cancer Research Centre), Pedro José Pinés Corrales(Servicio de Salud de Castilla La Mancha), Luis Robles Díaz(Hospital Universitario 12 De Octubre), Maria Carmen Martín(Spanish National Cancer Research Centre), Rocío Letón, Ángel M. Martínez‐Montes(Spanish National Cancer Research Centre), Eduardo Caleiras(Spanish National Cancer Research Centre)
Best Practice & Research Clinical Endocrinology & Metabolism
August 28, 2024
Cited by 10
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951